DE69614535T2 - Vorrichtung und verfahren zum aufbewahren und zur züchtung biologischer zellen - Google Patents
Vorrichtung und verfahren zum aufbewahren und zur züchtung biologischer zellenInfo
- Publication number
- DE69614535T2 DE69614535T2 DE69614535T DE69614535T DE69614535T2 DE 69614535 T2 DE69614535 T2 DE 69614535T2 DE 69614535 T DE69614535 T DE 69614535T DE 69614535 T DE69614535 T DE 69614535T DE 69614535 T2 DE69614535 T2 DE 69614535T2
- Authority
- DE
- Germany
- Prior art keywords
- cell growth
- cassette
- growth chamber
- medium
- chamber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract description 107
- 230000010261 cell growth Effects 0.000 claims abstract description 162
- 238000003306 harvesting Methods 0.000 claims abstract description 80
- 238000011081 inoculation Methods 0.000 claims abstract description 14
- 239000001963 growth medium Substances 0.000 claims description 79
- 238000012545 processing Methods 0.000 claims description 72
- 239000002609 medium Substances 0.000 claims description 63
- 239000007789 gas Substances 0.000 claims description 54
- 239000002699 waste material Substances 0.000 claims description 30
- 238000003860 storage Methods 0.000 claims description 20
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 18
- 229910052760 oxygen Inorganic materials 0.000 claims description 18
- 239000001301 oxygen Substances 0.000 claims description 18
- 230000033001 locomotion Effects 0.000 claims description 13
- 230000012010 growth Effects 0.000 claims description 12
- 230000003750 conditioning effect Effects 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 230000006835 compression Effects 0.000 claims description 5
- 238000007906 compression Methods 0.000 claims description 5
- 230000001143 conditioned effect Effects 0.000 claims description 5
- 238000001514 detection method Methods 0.000 claims description 3
- 230000000994 depressogenic effect Effects 0.000 claims description 2
- 230000008569 process Effects 0.000 abstract description 53
- 210000004027 cell Anatomy 0.000 description 183
- 210000001519 tissue Anatomy 0.000 description 57
- 239000003153 chemical reaction reagent Substances 0.000 description 31
- 238000004519 manufacturing process Methods 0.000 description 30
- 238000004113 cell culture Methods 0.000 description 26
- 210000000130 stem cell Anatomy 0.000 description 20
- 238000011534 incubation Methods 0.000 description 15
- 210000001185 bone marrow Anatomy 0.000 description 14
- 230000006870 function Effects 0.000 description 13
- 238000002659 cell therapy Methods 0.000 description 11
- 238000009826 distribution Methods 0.000 description 11
- 238000010899 nucleation Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 238000011109 contamination Methods 0.000 description 9
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 9
- 238000002560 therapeutic procedure Methods 0.000 description 9
- 230000000153 supplemental effect Effects 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 7
- 229920003023 plastic Polymers 0.000 description 7
- 230000004888 barrier function Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000012549 training Methods 0.000 description 6
- 238000002054 transplantation Methods 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 230000001464 adherent effect Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000006213 oxygenation reaction Methods 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 210000000601 blood cell Anatomy 0.000 description 4
- 239000007975 buffered saline Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000001415 gene therapy Methods 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 238000011072 cell harvest Methods 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 210000005260 human cell Anatomy 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 230000010412 perfusion Effects 0.000 description 3
- 238000004114 suspension culture Methods 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000010322 bone marrow transplantation Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000011194 good manufacturing practice Methods 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 210000002536 stromal cell Anatomy 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000003070 Statistical process control Methods 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000012787 harvest procedure Methods 0.000 description 1
- 238000011134 hematopoietic stem cell transplantation Methods 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000013386 optimize process Methods 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000001706 oxygenating effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 238000011028 process validation Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000012776 robust process Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000012414 sterilization procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 239000003634 thrombocyte concentrate Substances 0.000 description 1
- 230000030968 tissue homeostasis Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/54—Constructional details, e.g. recesses, hinges hand portable
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/42—Integrated assemblies, e.g. cassettes or cartridges
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M37/00—Means for sterilizing, maintaining sterile conditions or avoiding chemical or biological contamination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/48—Automatic or computerized control
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Sustainable Development (AREA)
- Clinical Laboratory Science (AREA)
- Analytical Chemistry (AREA)
- Computer Hardware Design (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48351995A | 1995-06-07 | 1995-06-07 | |
| US48351695A | 1995-06-07 | 1995-06-07 | |
| US48351795A | 1995-06-07 | 1995-06-07 | |
| US48351895A | 1995-06-07 | 1995-06-07 | |
| US48352095A | 1995-06-07 | 1995-06-07 | |
| PCT/US1996/009770 WO1996040858A1 (en) | 1995-06-07 | 1996-06-07 | Apparatus and method for maintaining and growing biological cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69614535D1 DE69614535D1 (de) | 2001-09-20 |
| DE69614535T2 true DE69614535T2 (de) | 2002-06-06 |
Family
ID=27541734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69614535T Expired - Lifetime DE69614535T2 (de) | 1995-06-07 | 1996-06-07 | Vorrichtung und verfahren zum aufbewahren und zur züchtung biologischer zellen |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0832182B1 (https=) |
| JP (1) | JP3880622B2 (https=) |
| AT (1) | ATE204322T1 (https=) |
| CA (1) | CA2223525C (https=) |
| DE (1) | DE69614535T2 (https=) |
| ES (1) | ES2162081T3 (https=) |
| WO (1) | WO1996040858A1 (https=) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE202018000370U1 (de) | 2018-01-24 | 2018-04-12 | Zellwerk Gmbh | Mäander-Bioreaktor für die Isolierung und Vermehrung von Zellen aus Gewebeteilen von Tumoren, Metastasen und anderen Geweben |
| DE202018004857U1 (de) | 2018-10-20 | 2019-01-14 | Zellwerk Gmbh | Mäander-Perfusions-Bioreaktor für die Differenzierung, Aktivierung, Stimulierung und Abtrennung von Zellen |
| DE102018000561A1 (de) | 2018-01-24 | 2019-07-25 | Zellwerk Gmbh | Mäander-Bioreaktor und Verfahren für die Isolierung und Vermehrung von Zellen aus Gewebeteilen von Tumoren, Metastasen und anderen Geweben |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6825169B1 (en) | 1991-10-22 | 2004-11-30 | Trustees Of Tufts College | Inhibitors of dipeptidyl-aminopeptidase type IV |
| US5965532A (en) * | 1996-06-28 | 1999-10-12 | Trustees Of Tufts College | Multivalent compounds for crosslinking receptors and uses thereof |
| US6040145A (en) | 1997-05-07 | 2000-03-21 | Tufts University | Potentiation of the immune response |
| US6100234A (en) | 1997-05-07 | 2000-08-08 | Tufts University | Treatment of HIV |
| ATE357509T1 (de) | 1997-09-29 | 2007-04-15 | Point Therapeutics Inc | Stimulierung von hämatopoietischen zellen im vitro |
| IL139247A0 (en) | 1998-05-04 | 2001-11-25 | Point Therapeutics Inc | Hematopoietic stimulation |
| JP2002517401A (ja) | 1998-06-05 | 2002-06-18 | ポイント セラピューティクス， インコーポレイテッド | 環状ボロプロリン化合物 |
| US6890904B1 (en) | 1999-05-25 | 2005-05-10 | Point Therapeutics, Inc. | Anti-tumor agents |
| FR2794130B1 (fr) * | 1999-05-26 | 2003-01-03 | Bertin Technologies Sa | Procede et dispositif de culture de cellules a applications multiples |
| ATE454442T1 (de) * | 1999-10-11 | 2010-01-15 | Dsm Ip Assets Bv | Kontinuierliche fermentation |
| WO2003087292A2 (en) * | 2002-04-08 | 2003-10-23 | Millenium Biologix Inc. | Automated tissue engineering system |
| JP4751566B2 (ja) * | 2002-04-09 | 2011-08-17 | オリンパス株式会社 | 細胞培養システム、培養細胞照合装置および細胞培養装置 |
| JP2004073187A (ja) * | 2002-06-18 | 2004-03-11 | Olympus Corp | 培養関連容器管理方法および培養関連容器 |
| CN100535098C (zh) * | 2004-01-14 | 2009-09-02 | 大金工业株式会社 | 温度控制装置 |
| GB0603965D0 (en) | 2006-02-28 | 2006-04-05 | Centeo Biosciences Ltd | Incubator apparatus and method |
| KR100932861B1 (ko) * | 2007-11-30 | 2009-12-21 | 코아스템(주) | 세포배양플라스크 |
| KR100946643B1 (ko) * | 2007-11-30 | 2010-03-09 | 코아스템(주) | 세포배양장치 및 이를 구비한 대용량 자동화 세포배양기 |
| CN102712886A (zh) | 2009-01-30 | 2012-10-03 | 埃米利奥·马特森塔曼斯 | 用于处理和储存细胞培养物的方法及模块设备 |
| DE102009029305A1 (de) | 2009-09-09 | 2011-03-10 | Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG | Analysegerät zur automatisierten Bestimmung einer Messgröße einer Flüssigkeitsprobe |
| CA2833001C (en) * | 2010-04-21 | 2020-06-23 | Octane Biotech, Inc. | Automated cell culture system |
| JP5351823B2 (ja) * | 2010-04-28 | 2013-11-27 | 株式会社日立ハイテクノロジーズ | 自動分析装置 |
| DE102012013267A1 (de) | 2012-07-04 | 2014-01-09 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Substrateinrichtung, Konservierungsgerät und Verfahren zur Kryokonservierung einer biologischen Probe |
| JP6051730B2 (ja) * | 2012-09-24 | 2016-12-27 | 東洋製罐グループホールディングス株式会社 | 気泡除去方法、及び気泡除去装置 |
| WO2016005971A1 (en) * | 2014-07-06 | 2016-01-14 | Fertilesafe Ltd | Devices for culturing a biological sample in a culturing liquid |
| JP6339432B2 (ja) * | 2014-07-16 | 2018-06-06 | オリンパス株式会社 | 細胞観察情報処理システム、細胞観察情報処理方法、細胞観察情報処理プログラム |
| FR3053051B1 (fr) | 2016-06-24 | 2022-11-11 | Cellprothera | Cassette et automate de culture cellulaire |
| SG11201901650YA (en) * | 2016-08-26 | 2019-03-28 | Ihi Corp | Cell culture system, culture unit, automatic cell culture device, and cell culture device for transport |
| US10406252B2 (en) | 2017-01-19 | 2019-09-10 | Curium Us Llc | Systems and methods for autoclave cart loading and unloading system |
| IL315340A (en) | 2017-09-01 | 2024-10-01 | Lonza Walkersville Inc | End-to-end cell therapy automation |
| EP3556841A1 (en) * | 2018-04-19 | 2019-10-23 | Aglaris Ltd | Disposable cartridge cooperating with a platform in a flexible system for handling and/or manipulating fluids |
| KR102816402B1 (ko) | 2018-09-28 | 2025-06-04 | 옥테인 바이오테크 인코포레이티드 | 자기 분리 |
| EP3898932A4 (en) | 2018-12-21 | 2022-08-03 | Octane Biotech Inc. | CAROUSEL FOR MODULAR BIOLOGICAL PRODUCTION UNITS |
| KR20210108406A (ko) | 2018-12-21 | 2021-09-02 | 론자 워커스빌 아이엔씨. | 바이러스 벡터의 자동화된 생산 |
| WO2020132743A1 (en) | 2018-12-28 | 2020-07-02 | Octane Biotech Inc. | Cell culture and tissue engineering systems with controlled environmental zones |
| WO2020163454A1 (en) | 2019-02-08 | 2020-08-13 | Lonza Walkersville, Inc. | Cell concentration methods and devices for use in automated bioreactors |
| JP7698625B2 (ja) * | 2019-07-15 | 2025-06-25 | ロンザ ウォーカーズヴィル，インコーポレーテッド | 自動細胞工学システム用のプロセス制御システム |
| EP4048773A4 (en) | 2019-10-24 | 2024-01-03 | Octane Biotech Inc. | CELL CULTURE CHAMBER WITH IMPROVED CELL CONTACT SURFACES |
| US12163146B2 (en) | 2019-11-11 | 2024-12-10 | Lonza Walkersville, Inc. | Quality control methods for automated cell processing |
| EP3933479A1 (en) * | 2020-07-03 | 2022-01-05 | Leica Microsystems CMS GmbH | Microscope for microscopic examination of a sample |
| WO2025202170A1 (en) * | 2024-03-25 | 2025-10-02 | The Automation Partnership (Cambridge) Limited | Mobile bioprocessing module, bioprocessing unit and bioprocessing system for performing a bioprocess |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3476895D1 (en) * | 1984-11-22 | 1989-04-06 | Personal Diagnostics Inc | Self-sufficient incubation assembly |
| AU6355790A (en) * | 1989-08-04 | 1991-03-11 | Peter Grandics | An integrated cell culture-protein purification system for the automated production and purification of cell culture products |
| JPH07501224A (ja) * | 1991-11-25 | 1995-02-09 | コーネル リサーチ ファウンデイション インコーポレイテッド | 自動化多区画細胞培養システム |
| US5612188A (en) * | 1991-11-25 | 1997-03-18 | Cornell Research Foundation, Inc. | Automated, multicompartmental cell culture system |
| US5352414A (en) * | 1992-12-30 | 1994-10-04 | Rothenberg Barry E | Incubator unit and filter system |
| US5424209A (en) * | 1993-03-19 | 1995-06-13 | Kearney; George P. | Automated cell culture and testing system |
-
1996
- 1996-06-07 AT AT96921439T patent/ATE204322T1/de not_active IP Right Cessation
- 1996-06-07 ES ES96921439T patent/ES2162081T3/es not_active Expired - Lifetime
- 1996-06-07 WO PCT/US1996/009770 patent/WO1996040858A1/en not_active Ceased
- 1996-06-07 CA CA002223525A patent/CA2223525C/en not_active Expired - Fee Related
- 1996-06-07 JP JP50199497A patent/JP3880622B2/ja not_active Expired - Fee Related
- 1996-06-07 EP EP96921439A patent/EP0832182B1/en not_active Expired - Lifetime
- 1996-06-07 DE DE69614535T patent/DE69614535T2/de not_active Expired - Lifetime
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE202018000370U1 (de) | 2018-01-24 | 2018-04-12 | Zellwerk Gmbh | Mäander-Bioreaktor für die Isolierung und Vermehrung von Zellen aus Gewebeteilen von Tumoren, Metastasen und anderen Geweben |
| DE102018000561A1 (de) | 2018-01-24 | 2019-07-25 | Zellwerk Gmbh | Mäander-Bioreaktor und Verfahren für die Isolierung und Vermehrung von Zellen aus Gewebeteilen von Tumoren, Metastasen und anderen Geweben |
| EP3517600A1 (de) | 2018-01-24 | 2019-07-31 | Zellwerk GmbH | Mäander-bioreaktor und verfahren für die isolierung und vermehrung von zellen aus gewebeteilen von tumoren, metastasen und anderen geweben |
| DE202018004857U1 (de) | 2018-10-20 | 2019-01-14 | Zellwerk Gmbh | Mäander-Perfusions-Bioreaktor für die Differenzierung, Aktivierung, Stimulierung und Abtrennung von Zellen |
| WO2020078498A1 (de) | 2018-10-20 | 2020-04-23 | Zellwerk Gmbh | Mäander-perfusions-bioreaktor für die differenzierung, aktivierung, stimulierung und abtrennung von zellen |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0832182B1 (en) | 2001-08-16 |
| CA2223525C (en) | 2008-12-23 |
| CA2223525A1 (en) | 1996-12-19 |
| DE69614535D1 (de) | 2001-09-20 |
| JPH11507229A (ja) | 1999-06-29 |
| JP3880622B2 (ja) | 2007-02-14 |
| ES2162081T3 (es) | 2001-12-16 |
| WO1996040858A1 (en) | 1996-12-19 |
| EP0832182A1 (en) | 1998-04-01 |
| ATE204322T1 (de) | 2001-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69614535T2 (de) | Vorrichtung und verfahren zum aufbewahren und zur züchtung biologischer zellen | |
| US5985653A (en) | Incubator apparatus for use in a system for maintaining and growing biological cells | |
| US5994129A (en) | Portable cassette for use in maintaining and growing biological cells | |
| US6228635B1 (en) | Portable cell growth cassette for use in maintaining and growing biological cells | |
| US6096532A (en) | Processor apparatus for use in a system for maintaining and growing biological cells | |
| US12365863B2 (en) | System and method for creating tissue | |
| US7906323B2 (en) | Automated bioculture and bioculture experiments system | |
| DE60013585T2 (de) | Kulturraum und Bioreaktor zur ausserkörperlichen Tierzellenkultur | |
| JP4195287B2 (ja) | 自動化されたバイオカルチャー及びバイオカルチャー実験システム | |
| JP3865354B2 (ja) | 細胞又は組織の培養方法 | |
| EP1194524B1 (de) | Bioreaktor | |
| DE2128744C3 (de) | Verfahren zur Massenkultivation von Zellen und Geweben | |
| EP1152053B1 (de) | Verfahren und Vorrichtung zur Herstellung eines vaskularisierten bioartifiziellen Gewebes | |
| JPH10512159A (ja) | 生物人工肝臓のための培養製品 | |
| EP3535383B1 (en) | Method for creating tissue | |
| US20050084951A1 (en) | Microcapillary bioreactor for growth of biological tissues | |
| US20230416669A1 (en) | Cassette and system for growth and treatment of cells | |
| US12618042B2 (en) | System and method for creating tissue | |
| EP0101715B1 (en) | Process and apparatus for controlling patterns of chemicals stimuli administration to biological tissue | |
| Armstrong et al. | Clinical systems for the production of cells and tissues for human therapy |